Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Genotropin--a Miracle Medicine that Makes Dwarves Grow Tall (China)

This article was originally published in PharmAsia News

Executive Summary

Pfizer's Swedish branch Pfizer Strangnas produces Genotropin, a growth hormone used by around 65,000 patients around the world to enable them to grow normally. These patients lack a human growth hormone, and without this drug they would become dwarves as adults. Pfizer Strangnas site leader Simon Orchard says the company eventually may set up distribution and manufacturing operations in China if conditions for doing so remain competitive. He says China and India are potential sites. Orchard says that the patient pool for this drug remains larger than the current tapped field, at around 180,000 worldwide. Production already is expanding at current manufacturing facilities. Orchard compares today's pharmaceutical industry to the electronic and car industries of past decades, when manufacturing moved to Asia in order to remain competitive. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC066354

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel